Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Deferred Taxes (2016 - 2018)

Historic Deferred Taxes for Niagen Bioscience (NAGE) over the last 8 years, with Q4 2018 value amounting to -$16000.0.

  • Niagen Bioscience's Deferred Taxes fell 10000.0% to -$16000.0 in Q4 2018 from the same period last year, while for Sep 2019 it was -$16000.0, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of $2000.0 for FY2018, which is 9888.89% down from last year.
  • Niagen Bioscience's Deferred Taxes amounted to -$16000.0 in Q4 2018, which was down 10000.0% from -$8000.0 recorded in Q3 2018.
  • In the past 5 years, Niagen Bioscience's Deferred Taxes registered a high of $321037.0 during Q4 2016, and its lowest value of -$50000.0 during Q1 2018.
  • Moreover, its 3-year median value for Deferred Taxes was -$8000.0 (2017), whereas its average is $50227.5.
  • In the last 5 years, Niagen Bioscience's Deferred Taxes skyrocketed by 108137.44% in 2016 and then crashed by 22500.0% in 2018.
  • Niagen Bioscience's Deferred Taxes (Quarter) stood at $321037.0 in 2016, then tumbled by 102.49% to -$8000.0 in 2017, then crashed by 100.0% to -$16000.0 in 2018.
  • Its Deferred Taxes stands at -$16000.0 for Q4 2018, versus -$8000.0 for Q3 2018 and $76000.0 for Q2 2018.